NeueHealth Inc. (NEUE)
NYSE: NEUE
· Real-Time Price · USD
6.36
-0.36 (-5.39%)
At close: Aug 15, 2025, 12:22 PM
NeueHealth Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 209.08M | 215.79M | 232.64M | 232.93M | 225.99M | 245.09M | 292.87M | 269.4M | 297.98M | 756.34M | 551.42M | 1.63B | 1.58B | 1.84B | 962.33M | 1.08B | 1.11B | 874.56M |
Cost of Revenue | 146.41M | 160.89M | 184.89M | 182.69M | 177.68M | 196.87M | 264.86M | 226.44M | 245.16M | 688.51M | n/a | n/a | -1.43B | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 62.67M | 54.89M | 47.75M | 50.24M | 48.31M | 48.22M | 28.01M | 42.96M | 52.82M | 67.83M | 551.42M | 1.63B | 3B | 1.84B | 962.33M | 1.08B | 1.11B | 874.56M |
Operating Income | 14.26M | 2.66M | -29.42M | -17.34M | -37.55M | -23.1M | -45.94M | -462.77M | -23.41M | -85.75M | -71.39M | -53.31M | -68.73M | -96.82M | 35.23M | -296.28M | -59.05M | -22.83M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 948K | n/a | n/a | n/a |
Pretax Income | 6.82M | -1.33M | -43.15M | -23.21M | -39.45M | 6.35M | -61.24M | -482.69M | -32.58M | -93.53M | -192.46M | -257.6M | -248.43M | -177.39M | -821.67M | -296.65M | -63.19M | -23.38M |
Net Income | -23.5M | -11.74M | -2.72M | -57.41M | -58.63M | -15.91M | -229.72M | -633.89M | -112.83M | -175.01M | -679.57M | -306.07M | -274.67M | -195.23M | -814.52M | -300.66M | -44.52M | -25.16M |
Selling & General & Admin | n/a | n/a | 84.83M | 60.32M | 66.2M | 62.34M | 56.51M | 66.2M | 64.58M | 129.21M | 93.09M | 85.58M | 79M | 96.79M | 252.34M | 309.79M | 261.06M | 208.24M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 194.82M | 213.13M | -7.67M | 7.26M | -74.21M | -71.38M | -51.11M | -99.07M | -74.95M | -150.22M | -163.26M | -387.57M | -386.49M | -431.22M | -370.9M | -313.59M | -267.27M | n/a |
Operating Expenses | 194.82M | 213.13M | 77.16M | 67.58M | 74.21M | 71.38M | 73.82M | 99.07M | 74.95M | 150.22M | 163.26M | 387.57M | 386.49M | 431.22M | 370.9M | 313.59M | 267.27M | 897.39M |
Interest Expense | 6.88M | 6.64M | 6.25M | 5.41M | 4.11M | 2.93M | 11.21M | 10.04M | 9.17M | 7.79M | 6.39M | 4.91M | 337K | 1.19M | 1.67M | 1.59M | 4.14M | 546K |
Selling & Marketing Expenses | n/a | n/a | -384K | 174K | 210K | n/a | -1.46M | 258K | 630K | 20.34M | -167.12M | 313K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 341.24M | 374.02M | 262.06M | 250.28M | -251.89M | -268.25M | 338.68M | 325.51M | 320.11M | 838.73M | -715.42M | -1.77B | -1.82B | -2.01B | -1.79B | -1.36B | -1.17B | 897.39M |
Income Tax Expense | -21K | 111K | -672K | 2.79M | -187K | 663K | 1.59M | -3.38M | -892K | 1.26M | -4.23M | 1.76M | 2.9M | 3.24M | -8.3M | 73K | -19.46M | 1.17M |
Shares Outstanding (Basic) | 8.75M | 8.57M | 8.23M | 8.28M | 8.25M | 8.08M | 7.95M | 7.98M | 7.96M | 7.89M | 7.88M | 7.87M | 7.87M | 7.86M | 7.86M | 7.85M | 7.82M | 1.75M |
Shares Outstanding (Diluted) | 8.75M | 8.57M | 8.23M | 8.28M | 8.25M | 8.08M | 7.95M | 7.98M | 7.96M | 7.89M | 7.88M | 7.87M | 7.87M | 7.86M | 7.86M | 7.85M | 7.82M | 1.75M |
EPS (Basic) | -2.63 | -2.9 | -1.94 | -8.51 | -7.1 | -1.97 | -28.88 | -79.47 | -14.17 | -22.17 | -86.26 | -38.88 | -34.92 | -24.84 | -103.66 | -38.29 | -5.69 | -14.36 |
EPS (Diluted) | -2.63 | -2.9 | -1.94 | -8.51 | -7.1 | -1.97 | -28.88 | -79.47 | -14.17 | -22.17 | -86.26 | -38.88 | -34.92 | -24.84 | -103.66 | -38.29 | -5.69 | -14.36 |
EBITDA | -13.09M | 8.87M | -33.3M | -14.3M | -31.36M | 13.84M | -46.01M | -468.53M | -18.74M | -25.53M | 65.92M | -103.91M | -35.93M | -163.94M | -810.49M | -282.08M | -51.85M | -18.25M |
EBIT | n/a | 5.31M | -36.9M | -17.8M | -35.34M | 9.28M | -50.03M | -472.65M | -23.41M | -44.87M | 55.51M | -95.92M | -71.52M | -159.08M | -820M | -295.06M | -59.05M | -22.83M |
Depreciation & Amortization | 3.56M | 3.56M | 3.6M | 3.5M | 3.98M | 4.56M | 4.03M | 4.12M | 4.67M | 9.89M | 10.4M | 13.9M | 13.23M | 13.04M | 9.5M | 14.21M | 7.2M | 22.83M |